Ensuring optimal brain function is paramount in today’s fast-paced environment, where mental demands are ever-rising. Introducing CogniCare Pro, a groundbreaking supplement meticulously crafted to elevate cognitive performance and promote overall brain health. This report delves deep into the realm of CogniCare Pro to illuminate its myriad benefits, potent ingredients, competitive pricing, and more, empowering you to make an informed choice regarding this avant-garde product.
Monday, February 22, 2021
FDA will evaluate claims and other information on a dietary supplement’s website to establish the product’s “intended use.” In general, a dietary supplement is allowed to make claims about having an effect on the “structure” or a “function” of the human body. If FDA finds that the product is intended for use in the cure, mitigation, treatment, or prevention of disease, it will be deemed a “drug” under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (“FD&C Act”). FDA routinely takes enforcement action against such unapproved new drugs.
In a February 18, 2021 Constituent Update, FDA announced that it had issued warning letters to 10 companies for illegally selling dietary supplements, containing a variety of ingredients, that all claim on their websites, as well as their Amazon product pages in some cases, to cure, treat, mitigate, or prevent depression and other mental health disorders as follows: